Matches in Wikidata for { <http://www.wikidata.org/entity/Q63844518> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q63844518 description "clinical trial" @default.
- Q63844518 description "ensayu clínicu" @default.
- Q63844518 description "klinisch onderzoek" @default.
- Q63844518 description "клінічне випробування" @default.
- Q63844518 name "Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus" @default.
- Q63844518 type Item @default.
- Q63844518 label "Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus" @default.
- Q63844518 prefLabel "Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus" @default.
- Q63844518 P1050 Q63844518-BBD11E9E-9C7D-45CF-9216-4E30526C7504 @default.
- Q63844518 P1132 Q63844518-A7A7B629-0C47-4F1C-8C72-414CBF36666F @default.
- Q63844518 P1476 Q63844518-929777EE-C25D-4001-B206-45A5B5B5D590 @default.
- Q63844518 P2283 Q63844518-DC39DAFC-CB48-4E0C-AD44-9FFA0D3F4EB4 @default.
- Q63844518 P2899 Q63844518-279E24FB-7E19-4F4C-A6D5-81EC70D4F70F @default.
- Q63844518 P3098 Q63844518-79D4BD73-808E-4E4A-9EA2-5DBAE59B33EF @default.
- Q63844518 P31 Q63844518-3EFF2C7B-B2FA-4F6F-A787-EA591856B9D5 @default.
- Q63844518 P4135 Q63844518-87D48014-A40F-4D50-9CA7-27793D1CC82D @default.
- Q63844518 P4844 Q63844518-8C4E3A82-BCC1-49E6-88A5-8EA6F448482F @default.
- Q63844518 P580 Q63844518-FEBD99D4-0FEC-47AA-879F-27A8E62F8CF2 @default.
- Q63844518 P582 Q63844518-B6DFA618-DA68-4676-87D1-2B54E44CF9C1 @default.
- Q63844518 P6099 Q63844518-5751DA01-C5ED-42CF-8C33-F425AD584835 @default.
- Q63844518 P8363 Q63844518-13DDB463-0760-4932-8493-C6AF3782C5EB @default.
- Q63844518 P859 Q63844518-29D4A64F-B4C6-4F90-AA23-DF87308F478C @default.
- Q63844518 P1050 Q194520 @default.
- Q63844518 P1132 "+301" @default.
- Q63844518 P1476 "Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus: A 52-Week Open-Label Follow-Up to Protocol 15-50310" @default.
- Q63844518 P2283 Q1755136 @default.
- Q63844518 P2899 "+40" @default.
- Q63844518 P3098 "NCT01586364" @default.
- Q63844518 P31 Q30612 @default.
- Q63844518 P4135 "+80" @default.
- Q63844518 P4844 Q412178 @default.
- Q63844518 P580 "2006-05-08T00:00:00Z" @default.
- Q63844518 P582 "2008-11-21T00:00:00Z" @default.
- Q63844518 P6099 Q42824827 @default.
- Q63844518 P8363 Q78089383 @default.
- Q63844518 P859 Q3482319 @default.